THERMOGENESIS HOLDINGS INC (THMO) Stock Price, Quote, News and Overview
NASDAQ:THMO - Nasdaq - US88362L2097 - Common Stock - Currency: USD
THMO Quote, Performance and Key Statistics
0.3102
-0.11 (-25.84%)
The current stock price of THMO is 0.3102 USD. In the past month the price decreased by -40.41%. In the past year, price decreased by -76.85%.
THMO Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.07 | 224.39B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.51 | 182.05B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.46 | 149.59B | ||
| SYK | STRYKER CORP | 29.62 | 137.81B | ||
| MDT | MEDTRONIC PLC | 15.79 | 108.12B | ||
| BDX | BECTON DICKINSON AND CO | 14.7 | 58.71B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.9 | 44.17B | ||
| IDXX | IDEXX LABORATORIES INC | 39.2 | 35.74B | ||
| RMD | RESMED INC | 26 | 34.68B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.94 | 30.71B | ||
| DXCM | DEXCOM INC | 42.9 | 27.75B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 15.65 | 23.24B |
Related stock screener links
About THMO
Company Profile
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California and currently employs 40 full-time employees. The company provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and the CAR-TXpress platform for large scale cell manufacturing services. Its products include Clinical Bio-Banking Applications, Point-of-Care Applications and Large-Scale Cell Processing and Biomanufacturing. Its Clinical Bio-Banking Applications include AXP Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Its Large-Scale Cell Processing and Biomanufacturing includes X-Series Products for general laboratory use and CAR-TXpress Platform for Clinical Manufacturing. AXP Automated Cell Separation System is an automated, fully closed cell separation system.
Company Info
THERMOGENESIS HOLDINGS INC
2711 Citrus Rd
Rancho Cordova CALIFORNIA 95742 US
CEO: Chris Xu
Employees: 40
Company Website: https://thermogenesis.com
Phone: 19168585100
THERMOGENESIS HOLDINGS INC / THMO FAQ
What is the stock price of THERMOGENESIS HOLDINGS INC today?
The current stock price of THMO is 0.3102 USD. The price decreased by -25.84% in the last trading session.
What is the ticker symbol for THERMOGENESIS HOLDINGS INC stock?
The exchange symbol of THERMOGENESIS HOLDINGS INC is THMO and it is listed on the Nasdaq exchange.
On which exchange is THMO stock listed?
THMO stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for THERMOGENESIS HOLDINGS INC stock?
7 analysts have analysed THMO and the average price target is 5.1 USD. This implies a price increase of 1544.1% is expected in the next year compared to the current price of 0.3102. Check the THERMOGENESIS HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is THERMOGENESIS HOLDINGS INC worth?
THERMOGENESIS HOLDINGS INC (THMO) has a market capitalization of 2.47M USD. This makes THMO a Nano Cap stock.
How many employees does THERMOGENESIS HOLDINGS INC have?
THERMOGENESIS HOLDINGS INC (THMO) currently has 40 employees.
What are the support and resistance levels for THERMOGENESIS HOLDINGS INC (THMO) stock?
THERMOGENESIS HOLDINGS INC (THMO) has a resistance level at 0.59. Check the full technical report for a detailed analysis of THMO support and resistance levels.
Is THERMOGENESIS HOLDINGS INC (THMO) expected to grow?
The Revenue of THERMOGENESIS HOLDINGS INC (THMO) is expected to grow by 48.46% in the next year. Check the estimates tab for more information on the THMO EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy THERMOGENESIS HOLDINGS INC (THMO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of THMO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of THMO, evaluating the profitability, health, valuation and growth aspects
- THERMOGENESIS HOLDINGS INC (THMO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- THERMOGENESIS HOLDINGS INC (THMO) Sales and EPS estimates to see what analysts future expectations are.
- THERMOGENESIS HOLDINGS INC (THMO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- THERMOGENESIS HOLDINGS INC (THMO) Insider and Institutional Ownership to learn about the owners and their transactions.
- THERMOGENESIS HOLDINGS INC (THMO) Stock Chart to make your own analysis
- THERMOGENESIS HOLDINGS INC (THMO) Latest news and press-releases to stay up to date.
Does THERMOGENESIS HOLDINGS INC (THMO) stock pay dividends?
THMO does not pay a dividend.
When does THERMOGENESIS HOLDINGS INC (THMO) report earnings?
THERMOGENESIS HOLDINGS INC (THMO) will report earnings on 2024-08-08, after the market close.
What is the Price/Earnings (PE) ratio of THERMOGENESIS HOLDINGS INC (THMO)?
THERMOGENESIS HOLDINGS INC (THMO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.28).
What is the Short Interest ratio of THERMOGENESIS HOLDINGS INC (THMO) stock?
The outstanding short interest for THERMOGENESIS HOLDINGS INC (THMO) is 0.01% of its float. Check the ownership tab for more information on the THMO short interest.
THMO Technical Analysis
THMO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to THMO. THMO may be in some trouble as it scores bad on both profitability and health.
THMO Financial Highlights
Over the last trailing twelve months THMO reported a non-GAAP Earnings per Share(EPS) of -4.28. The EPS increased by 76.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -146.23% | ||
| ROE | -1512.82% | ||
| Debt/Equity | 4.31 |
THMO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to THMO. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 102.13% and a revenue growth 48.46% for THMO